Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype

Pharmacological Research

Volumn 99, Issue , 2015, Pages 229-236

  Merighi, Stefania ^a   Borea, Pier Andrea ^a   Gessi, Stefania ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Adenosine receptors; Diabetes; Inflammation; Therapeutic target

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE KINASE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CD39 ANTIGEN; CYCLIC AMP; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE; MESSENGER RNA; NETRIN 1; NUCLEOSIDE TRANSPORTER; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST;

BINDING AFFINITY; CALCIUM CELL LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOLECULAR DYNAMICS; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PURINERGIC SIGNALING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM;

ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; DIABETES MELLITUS; HUMANS; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

EID: 84937560846     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.06.015     Document Type: Review

References (123)

1. 1 adenosine receptors in diabetes treatment Curr. Pharm. Design 16 2010 4237 4242
2. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res. Clin. Pract. 94 2011 311 321
3. P. Concannon, S.S. Rich, and G.T. Nepom Genetics of type 1A diabetes N. Engl. J. Med. 360 2009 1646 1654
4. T.L. van Belle, K.T. Coppieters, and M.G. von Herrath Type 1 diabetes: etiology, immunology, and therapeutic strategies Physiol. Rev. 91 2011 79 118
5. J. Tuomilehto, J. Lindström, J.G. Eriksson, T.T. Valle, H. Hämäläinen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen, and M. Uusitupa Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 344 2001 1343 1350
6. M. Stumvoll, B.J. Goldstein, and T.W. van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 2005 1333 1346
7. O. Osborn, and J.M. Olefsky The cellular and signaling networks linking the immune system and metabolism in disease Nat. Med. 18 2012 363 374
8. G. Burnstock, and I. Novak Purinergic signalling and diabetes Purinergic Signal. 9 2013 307 324
9. O. Andersson Role of adenosine signalling and metabolism in β-cell regeneration Exp. Cell Res. 321 2014 3 10
10. S. Bacher, O. Kraupp, W. Conca, and G. Raberger The effects of NECA (adenosine-5′-N-ethylcarboxamide) and of adenosine on glucagon and insulin release from the in situ isolated blood-perfused pancreas in anesthetized dogs N-S Arch. Pharmacol. 320 1982 67 71
11. G. Raberger, T. Benke, and O. Kraupp The effect of adenosine-5′-ethylcarboxamide on liver blood flow and hepatic glucose, lactate and pyruvate balances in dogs N-S Arch. Pharmacol. 314 1980 281 284
12. R.A. Challiss, S.J. Richards, and L. Budohoski Characterization of the adenosine receptor modulating insulin action in rat skeletal muscle Eur. J. Pharmacol. 226 1992 121 128
13. J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection Annu. Rev. Pharmacol. 41 2001 775 787
14. R. Romagnoli, P.G. Baraldi, M.A. Tabrizi, S. Gessi, P.A. Borea, and S. Merighi Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development Curr. Med. Chem. 17 2010 3488 3502
15. B.B. Fredholm Adenosine receptors as drug targets Exp. Cell Res. 316 2010 1284 1288
16. S. Gessi, S. Merighi, V. Sacchetto, C. Simioni, and P.A. Borea Adenosine receptors and cancer BBA - Biomembranes 1808 2011 1400 1412
17. T. Porkka-Heiskanen, and A.V. Kalinchuk Adenosine, energy metabolism and sleep homeostasis Sleep Med. Rev. 15 2011 123 135
18. Z.H. Németh, D. Bleich, B. Csóka, P. Pacher, J.G. Mabley, L. Himer, E.S. Vizi, E.A. Deitch, C. Szabó, B.N. Cronstein, and G. Haskó Adenosine receptor activation ameliorates type 1 diabetes FASEB J. 21 2007 2379 2388
19. 1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance Diabetes Obes. Metab. 3 2001 360 366
20. M.R. Blackburn Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice TIPS 24 2003 66 70
21. D.H. Han, P.A. Hansen, L.A. Nolte, and J.O. Holloszy Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions Diabetes 47 1998 1671 1675
22. 2b adenosine receptor modulates glucose homeostasis and obesity PLoS ONE 7 2012 e40584
23. 2A receptors modulate insulinemia, glycemia and lactatemia in fetal sheep Am. J. Physiol. Reg. I. 296 2009 R693 R701
24. 1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue - interactions with insulin Eur. J. Pharmacol. 597 2008 92 101
25. Z. Peng, P.A. Borea, K. Varani, T. Wilder, H. Yee, L. Chiriboga, M.R. Blackburn, G. Azzena, G. Resta, and B.N. Cronstein Adenosine signaling contributes to ethanol-induced fatty liver in mice J. Clin. Invest. 119 2009 582 594
26. 2b adenosine receptor regulates hyperlipidemia and atherosclerosis Circulation 125 2012 354 363
27. S. Gessi, E. Fogli, V. Sacchetto, S. Merighi, K. Varani, D. Preti, E. Leung, S. Maclennan, and P.A. Borea Adenosine modulates HIF-1alpha, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells Arterioscler. Thromb. Vasc. 30 2010 90 97
28. 3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics 2010 Springer Netherlands 281 288
29. J. Linden Adenosine in tissue protection and tissue regeneration Mol. Pharmacol. 67 2005 1385 1387
30. R. Polosa Finding better therapeutic targets for patients with asthma: adenosine receptors? Br. J. Pharmacol. 155 2008 441 443
31. 2A receptor-unrelated lymphotoxicity Br. J. Pharmacol. 131 2000 43 50
32. 2A adenosine receptor in vivo J. Immunol. 173 2004 21 24
33. A. Ohta, and M. Sitkovsky Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage Nature 414 2001 916 920
34. 2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines J. Pharmacol. Exp. Ther. 324 2008 694 700
35. 2B adenosine receptor protects against inflammation and excessive vascular adhesion J. Clin. Invest. 116 2006 1913 1923
36. 2b adenosine receptor protects against vascular injury PNAS 105 2008 792 796
37. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, J. Linden, and C.E. Müller International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update Pharmacol. Rev. 63 2011 1 34
38. 3 adenosine receptor: history and perspectives Pharmacol. Rev. 67 2015 74 102
39. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.-N. Klotz, and J. Linden International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
40. S. Gessi, S. Merighi, D. Fazzi, A. Stefanelli, K. Varani, and P.A. Borea Adenosine receptor targeting in health and disease Expert Opin. Investig. Drug 20 2011 1591 1609
41. S. Gessi, S. Merighi, K. Varani, and P.A. Borea Adenosine receptors in health and disease Adv. Pharmacol. 61 2011 41 75
42. 1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats Am. J. Physiol. Endocrinol. Metab. 257 1989 E871 E878
43. L. Heseltine, J.M. Webster, and R. Taylor Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes Mol. Cell. Biochem. 144 1995 147 151
44. 1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies Diabetes 53 2004 1920 1926
45. 1 receptor deficiency causes increased insulin and glucagon secretion in mice Biochem. Pharmacol. 74 2007 1628 1635
46. 1 receptor signaling Diabetes 60 2011 2578 2587
47. 1 receptor dependent glucose metabolism Adipocyte 1 2012 108 111
48. 1 receptor knockout mice Am. J. Physiol. Endocrinol. Metab. 303 2012 E180 E190
49. 1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy Neuroscience 285 2015 312 323
50. 1 adenosine receptor: role in diabetes and obesity Handb. Exp. Pharmacol. 193 2009 271 295
51. M. Koupenova, and K. Ravid Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism J. Cell. Physiol. 2013 10.1002/jcp.24352
52. L. Antonioli, C. Blandizzi, B. Csóka, P. Pacher, and G. Haskó Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations Nat. Rev. Endocrinol. 11 2015 228 241
53. M. Grden, M. Podgorska, A. Szutowicz, and T. Pawelczyk Diabetes-induced alterations of adenosine receptors expression level in rat liver Exp. Mol. Pathol. 83 2007 392 398
54. M. Grden, M. Podgórska, A. Szutowicz, and T. Pawelczyk Altered expression of adenosine receptors in heart of diabetic rat J. Physiol. Pharmacol. 56 2005 587 597
55. T. Pawelczyk, M. Grden, R. Rzepko, M. Sakowicz, and A. Szutowicz Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat Am. J. Pathol. 167 2005 315 325
56. 3AR-dependent vasoconstriction in diabetic mice is promoted by myeloperoxidase J. Cardiovasc. Pharmacol. 64 2014 465 472
57. 3 adenosine receptors Am. J. Physiol. Endocrinol. Metab. 290 2006 E940 E951
58. 3 adenosine receptors Auton. Autacoid Pharmacol. 29 2009 157 164
59. 3 receptors in modulation of insulin secretion and β-cell survival in mouse pancreatic islets Gen. Comp. Endocrinol. 187 2013 86 94
60. 3 adenosine receptor: a plausible therapeutic target for cardio-protection in diabetes Recent Pat. Cardiovasc. Drug Discov. 7 2012 59 70
61. 3 adenosine receptor deficiency does not influence atherogenesis J. Cell. Biochem. 92 2004 1034 1043
62. 2+ and cAMP Eur. J. Pharmacol. 437 2002 105 111
63. N. Yasuda, T. Inoue, T. Horizoe, K. Nagata, H. Minami, T. Kawata, Y. Hoshino, H. Harada, S. Yoshikawa, O. Asano, J. Nagaoka, M. Murakami, S. Abe, S. Kobayashi, and I. Tanaka Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes Eur. J. Pharmacol. 459 2003 159 166
64. 2A agonist administration improves islet transplant outcome: evidence for the role of innate immunity in islet graft rejection Cell Transplant. 19 2010 597 612
65. 2A receptors in ischemia reperfusion injury and islet transplantation Curr. Diabetes Rev. 8 2012 419 433
66. O. Andersson, B.A. Adams, D. Yoo, G.C. Ellis, P. Gut, R.M. Anderson, M.S. German, and D.Y. Stainier Adenosine signaling promotes regeneration of pancreatic β cells in vivo Cell Metab. 15 2012 885 894
67. J.S. Chia, J.L. McRae, H.E. Thomas, S. Fynch, L. Elkerbout, P. Hill, L. Murray-Segal, S.C. Robson, J.F. Chen, A.J. d'Apice, P.J. Cowan, and K.M. Dwyer The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice Diabetes 62 2013 2026 2035
68. T. Pawelczyk, M. Sakowicz-Burkiewicz, K. Kocbuch, and A. Szutowicz Differential effect of insulin and elevated glucose level on adenosine handling in rat T lymphocytes J. Cell. Biochem. 96 2005 1296 1310
69. M. Sakowicz-Burkiewicz, K. Kocbuch, M. Grden, A. Szutowicz, and T. Pawelczyk Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes Immunology 118 2006 402 412
70. M.D. Valls, B.N. Cronstein, and M.C. Montesinos Adenosine receptor agonists for promotion of dermal wound healing Biochem. Pharmacol. 77 2009 1117 1124
71. 2A receptors Am. J. Pathol. 160 2002 2009 2018
72. 2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial J. Clin. Endocrinol. Metab. 99 2014 E746 E753
73. B.N. Cronstein Adenosine receptors and wound healing, revised Sci. World J. 6 2006 984 991
74. A.B. Reiss, S.E. Carsons, K. Anwar, S. Rao, S.D. Edelman, H. Zhang, P. Fernandez, B.N. Cronstein, and E.S. Chan Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages Arthritis Rheumatol. US 58 2008 3675 3683
75. 2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages J. Leukocyte Biol. 76 2004 727 734
76. 2A receptor protects apolipoprotein E-deficient mice from atherosclerosis Arterioscler. Thromb. Vasc. 29 2009 1046 1052
77. B.B. Fredholm Adenosine, an endogenous distress signal, modulates tissue damage and repair Cell Death Differ. 14 2007 1315 1323
78. 2B receptor in hypoxia FASEB J. 20 2006 2242 2250
79. 2B receptor J. Med. Chem. 44 2001 170 179
80. 2B adenosine receptor Bioorg. Med. Chem. 9 2001 2709 2726
81. 2B receptors on glucose homoeostasis J. Pharm. Pharmacol. 58 2006 1639 1645
82. 2B receptors, and inflammatory markers in mice and humans Diabetes 60 2011 669 679
83. 2B adenosine receptor regulates tissue insulin sensitivity PLOS ONE 9 2014 e98775
84. 2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation Diabetes 63 2014 850 866
85. C. Chawla, K.D. Nguyen, and Y.P. Goh Macrophage-mediated inflammation in metabolic disease Nat. Rev. Immunol. 11 2011 738 749
86. 2B receptors FASEB J. 26 2012 376 386
87. B. Koscsó, B. Csóka, E. Kókai, Z.H. Németh, P. Pacher, L. Virág, S.J. Leibovich, and G. Haskó Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages J. Leukocyte Biol. 94 2013 1309 1315
88. 2B adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus Diabetes/Metab. Res. Rev. 30 2014 42 53
89. C. Quezada, S. Alarcón, C. Jaramillo, D. Muñoz, C. Oyarzún, and R. San Martín Targeting adenosine signaling to treatment of diabetic nephropathy Curr. Drug Targets 14 2013 490 496
90. R. San Martín, D. Valladares, H. Roa, E. Troncoso, and L. Sobrevia Do adenosine receptors offer new therapeutic options for diabetic nephropathy? Curr. Vasc. Pharmacol. 7 2009 450 459
91. S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, C. Simioni, E. Leung, S. Maclennan, P.G. Baraldi, and P.A. Borea Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells Mol. Pharmacol. 72 2007 395 406
92. 2B receptor-mediated vascular endothelial growth factor production Mol. Pharmacol. 85 2014 62 73
93. S. Ryzhov, J.L. McCaleb, A.E. Goldstein, I. Biaggioni, and I. Feoktistov Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia J. Pharmacol. Exp. Ther. 320 2007 565 572
94. 2B adenosine receptors in human trisomy 21 mesenchymal cells from first-trimester chorionic villi BBA Mol. Basis Dis. 1822 2012 1660 1670
95. 2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy Ren. Fail. 36 2014 916 924
96. 2B receptor-mediated VEGF induction promotes diabetic glomerulopathy Lab. Investig. 93 2013 135 144
97. H. Roa, C. Gajardo, E. Troncoso, V. Fuentealba, C. Escudero, A. Yáñez, L. Sobrevia, M. Pastor-Anglada, C. Quezada, and R. San Martin Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats FEBS Lett. 583 2009 3192 3198
98. E. Tak, D. Ridyard, J.H. Kim, M. Zimmerman, T. Werner, X.X. Wang, U. Shabeka, S.W. Seo, U. Christians, J. Klawitter, R. Moldovan, G. Garcia, M. Levi, V. Haase, K. Ravid, H.K. Eltzschig, and A. Grenz CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy J. Am. Soc. Nephrol. 25 2014 547 563
99. E. Tak, D. Ridyard, A. Badulak, A. Giebler, U. Shabeka, T. Werner, E. Clambey, R. Moldovan, M.A. Zimmerman, H.K. Eltzschig, and A. Grenz Protective role for netrin-1 during diabetic nephropathy J. Mol. Med. 91 2013 1071 1080
100. P. Rosenberger, J.M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J.C. Morote-Garcia, K. Unertl, and H.K. Eltzschig Hypoxia-inducible factor dependent induction of netrin-1 dampens inflammation caused by hypoxia Nat. Immunol. 10 2009 195 202
101. H.K. Eltzschig, M.V. Sitkovsky, and S.C. Robson Purinergic signaling during inflammation N. Engl. J. Med. 367 2012 2322 2333
102. J.S. Chia, J.L. McRae, P.J. Cowan, and K.M. Dwyer The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes J. Biomed. Biotechnol. 2012 2012 320 495
103. K. Enjyoji, K. Kotani, C. Thukral, B. Blumel, X. Sun, Y. Wu, M. Imai, D. Friedman, E. Csizmadia, W. Bleibel, B.B. Kahn, and S.C. Robson Deletion of cd39/entpd1 results in hepatic insulin resistance Diabetes 57 2008 2311 2320
104. N. Tai, F.S. Wong, and L. Wen TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice J. Immunol. 191 2013 2926 2937
105. G.I. Lunkes, D.S. Lunkes, V.M. Morsch, C.M. Mazzanti, A.L. Morsch, V.R. Miron, and M.R. Schetinger NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes Diabetes Res. Clin. Pract. 65 2004 1 6
106. 7 receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters Cell Immunol. 269 2011 135 143
107. 2A receptors in cells from subjects with obesity and type 2 diabetes mellitus Immunobiology 220 2015 976 984
108. A.B. Sobol, and C. Watala The role of platelets in diabetes-related vascular complications Diabetes Res. Clin. Pract. 50 2000 1 16
109. G.I. Lunkes, D. Lunkes, F. Stefanello, A. Morsch, V.M. Morsch, C.M. Mazzanti, and M.R. Schetinger Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies Thromb. Res. 109 2003 189 194
110. K. Kocbuch, M. Sakowicz-Burkiewicz, M. Grden, A. Szutowicz, and T. Pawelczyk Effect of insulin and glucose on adenosine metabolizing enzymes in human B lymphocytes Acta Biochim. Pol. 56 2009 439 446
111. T. Pawelczyk, M. Podgorska, and M. Sakowicz The effect of insulin on expression level of nucleoside transporters in diabetic rats Mol. Pharmacol. 63 2003 81 88
112. M. Löffler, J.C. Morote-Garcia, S.A. Eltzschig, I.R. Coe, and H.K. Eltzschig Physiological roles of vascular nucleoside transporters Arterioscler. Thromb. Vasc. 27 2007 1004 1013
113. G.P. Leung, R.Y. Man, and C.M. Tse D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2756 H2762
114. M. Podgorska, K. Kocbuch, M. Grden M, A. Szutowicz, and T. Pawelczyk Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters J. Physiol. 576 Pt 1 2006 179 189
115. M. Grden, M. Podgorska, K. Kocbuch, R. Rzepko, A. Szutowicz, and T. Pawelczyk T High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-zeta and MAP kinases J. Cell Physiol. 215 2008 151 160
116. N.M. Elsherbiny, S. Ahmad, M. Naime, A.M. Elsherbini, S. Fulzele, M.M. Al-Gayyar, L.A. Eissa, M.M. El-Shishtawy, and G.I. Liou ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy Life Sci. 93 2013 78 88
117. C. Pye, N.M. Elsherbiny, A.S. Ibrahim, G.I. Liou, A. Chadli, M. Al-Shabrawey, and A.A. Elmarakby Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms Pharmacol. Res. 85 2014 45 54
118. T. Pawelczyk, M. Sakowicz, M. Szczepanska-Konkel, and S. Angielski Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats Arch. Biochem. Biophys. 375 2000 1 6
119. D. Boison Adenosine kinase: exploitation for therapeutic gain Pharmacol. Rev. 65 2013 906 943
120. M. Samsel, K. Dzierzbicka, and P. Trzonkowski Adenosine, its analogues and conjugates Postepy Hig. Med. Dosw. 67 2013 1189 1203
121. M. Samsel, and K. Dzierzbicka Therapeutic potential of adenosine analogues and conjugates Pharmacol. Rep. 63 2011 601 617
122. P.M. Staehr, A.K. Dhalla, J. Zack, X. Wang, Y.L. Ho, J. Bingham, and L. Belardinelli Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist J. Clin. Pharmacol. 53 2013 385 392
123. 2b adenosine receptor in cardiovascular and metabolic diseases J. Cell. Physiol. 2015 (in press)